MarketFriction

Adinath Bio-Labs Ltd

BSE 590088 · Biotechnology
Market cap₹6.62 Cr.
Not trading

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore
Mar 2014Jun 2014Sep 2014Dec 2014Mar 2015Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016
Sales5.780.300.280.320.450.220.220.180.190.190.160.11
Expenses6.130.220.200.220.320.320.140.130.140.150.120.08
Operating Profit-0.350.080.080.100.13-0.100.080.050.050.040.040.03
OPM %-6.06%26.67%28.57%31.25%28.89%-45.45%36.36%27.78%26.32%21.05%25.00%27.27%
Other Income0.040.030.020.020.000.380.000.000.000.000.000.00
Interest0.000.000.000.000.000.000.000.000.000.000.000.00
Depreciation0.070.050.050.050.120.040.040.040.040.030.030.03
Profit before tax-0.380.060.050.070.010.240.040.010.010.010.010.00
Tax %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Net Profit-0.380.050.040.060.010.240.040.010.010.010.010.01
EPS in Rs-0.020.000.000.000.000.010.000.000.000.000.000.00
Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Sales21.8232.5056.4542.1742.851.001.350.810.560.050.000.00
Expenses20.1030.3055.4241.0941.890.730.970.730.421.830.550.53
Operating Profit1.722.201.031.080.960.270.380.080.14-1.78-0.55-0.53
OPM %7.88%6.77%1.82%2.56%2.24%27.00%28.15%9.88%25.00%-3,560.00%
Other Income0.090.090.230.180.130.160.070.380.01-4.43-1.96-2.88
Interest0.000.000.000.000.000.000.000.000.000.000.000.01
Depreciation0.310.330.390.560.400.290.280.160.110.090.010.01
Profit before tax1.501.960.870.700.690.140.170.300.04-6.30-2.52-3.43
Tax %34.67%3.06%0.00%2.86%0.00%0.00%-5.88%53.33%25.00%11.59%-0.79%0.00%
Net Profit0.981.900.870.680.700.140.170.140.02-7.03-2.51-3.42
EPS in Rs0.040.090.040.030.030.010.010.010.00-0.32-0.11-0.15
Dividend Payout %67.56%69.69%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth%%%%
Compounded Profit Growth%%%2%
Stock Price CAGR5%%%%
Return on Equity0%-4%-13%-12%
Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Equity Capital22.0722.0722.0722.0722.0722.0722.0722.0722.0722.0722.0722.07
Reserves4.374.725.596.276.977.117.087.23-6.44-13.47-15.97-19.40
Borrowings0.000.000.000.000.000.000.000.000.000.000.000.00
Other Liabilities1.381.900.270.180.160.140.170.190.190.950.860.87
Total Liabilities27.8228.6927.9328.5229.2029.3229.3229.4915.829.556.963.54
Fixed Assets3.253.532.011.861.471.180.710.560.440.260.020.02
CWIP1.862.222.271.871.871.871.871.871.870.000.000.00
Investments1.271.271.270.560.562.962.960.560.540.030.030.03
Other Assets21.4421.6722.3824.2325.3023.3123.7826.5012.979.266.913.49
Total Assets27.8228.6927.9328.5229.2029.3229.3229.4915.829.556.963.54
Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Cash from Operating Activity-0.131.05-1.41-0.92-0.13-0.06-0.13-2.600.12-0.54-0.01-0.03
Cash from Investing Activity0.14-0.881.310.890.130.130.072.58-0.170.520.020.03
Cash from Financing Activity0.000.000.000.000.000.000.000.000.000.000.000.00
Net Cash Flow0.010.17-0.10-0.030.000.07-0.06-0.02-0.05-0.020.010.00
Free Cash Flow-0.130.09-0.33-0.92-0.13-2.46-0.13-2.610.12-0.44-0.01-0.03
CFO/OP23%71%-131%-84%-14%-22%-34%-3,112%86%30%2%6%
Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Debtor Days124.4588.6147.1475.0466.702,562.30121.67279.38404.114,526.00
Inventory Days113.2677.6021.5228.5128.770.00
Days Payable0.372.351.000.450.27
Cash Conversion Cycle237.35163.8667.65103.1095.202,562.30121.67279.38404.114,526.00
Working Capital Days335.06219.6769.19101.5393.613,701.1083.81198.271,088.482,190.00
ROCE %5.69%7.36%3.20%2.50%2.41%0.48%0.58%0.38%0.18%-11.39%-7.21%-11.63%
Jun 2016Sep 2016Dec 2016
Promoters25.75%25.75%25.75%
Public74.25%74.25%74.25%
No. of Shareholders5,9555,9675,830

Fundamentals

Market Cap₹ 6.62 Cr.
Current Price₹ 0.30
Book Value₹ 0.12
ROCE-11.6 %
ROE-11.6 %
Dividend Yield0.00 %
Face Value₹ 1.00
Compounded Sales Growth (TTM)%
Compounded Profit Growth (TTM)2%
Standalone figures.
Valuation
P/B, 3-year average1.45x
P/E, 5-year average180.54x
P/B, 5-year average0.98x
Profitability
EBITDA margin-506.15%
Pre-tax margin-527.69%
Net profit margin6.15%
Net margin, latest quarter9.09%
ROE-77.99%
ROCE-77.99%
ROA-65.14%
ROE, 3-year average-56.72%
ROCE, 3-year average-54.76%
ROA, 3-year average-50.32%
ROE, 5-year average-33.92%
ROCE, 5-year average-32.62%
ROA, 5-year average-30.08%
ROIC (approx.)-129.06%
Other income / net worth-107.87%
Growth
Sales growth QoQ-31.25%
Profit growth QoQ0.00%
Sales growth YoY (latest quarter)-38.89%
Profit growth YoY (latest quarter)0.00%
Per share
EPS (TTM)Rs 0.00
EPS (latest year)Rs -0.15
EPS (latest quarter)Rs 0.00
EPS, 3-year averageRs -0.20
EPS, 5-year averageRs -0.12
Book value per shareRs 0.12
Sales per shareRs 0.03
Cash flow per shareRs -0.00
Free cash flow per shareRs -0.00
Efficiency
Creditor days0 days
Cash conversion cycle4526 days
Working capital days2190 days
Leverage
Cash and bankRs 0 Cr
Net debtRs -0 Cr
Interest coverage-342.00x
Owners' fund to total sources75.42%
Cash flow
Cash from Operating Activity (latest year)Rs -0 Cr
Cash from Investing Activity (latest year)Rs 0 Cr
Free cash flow (latest year)Rs -0 Cr
Statement figures
Net sales (TTM)Rs 1 Cr
Sales (latest quarter)Rs 0 Cr
Operating profit (latest quarter)Rs 0 Cr
Other income (TTM)Rs -3 Cr
EBITDA (TTM)Rs -3 Cr
PBDT (TTM)Rs -3 Cr
Profit before tax (TTM)Rs -3 Cr
Net profit (TTM)Rs 0 Cr
Net profit (latest year)Rs -3 Cr
Net profit (latest quarter)Rs 0 Cr
Depreciation (TTM)Rs 0 Cr
Depreciation (latest quarter)Rs 0 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 0 Cr
Total income (latest year)Rs -3 Cr
Share capitalRs 22 Cr
ReservesRs -19 Cr
Shareholders' fundsRs 3 Cr
Total assetsRs 4 Cr
Net blockRs 0 Cr
InvestmentsRs 0 Cr
Other liabilitiesRs 1 Cr
Shares outstanding (crore)22.07
Ownership
Promoter holding25.75%
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
Not enough price history.

Red flags

F-score 3 of 6
lookRepeated losses Net loss in each of the last two years
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Dec 2016
Sales ₹0 Cr -38.9% vs Dec 2015. Net profit ₹0 Cr +0.0%.

Activity

Compare
CompanyMcap (Cr)P/EROCE
Anthem Biosciences Ltd48,99682.630.4 %
Advanced Enzyme Technologies Ltd3,15220.014.0 %
CCME Global Ltd208-2.92 %
Vivo Bio Tech Ltd367.74 %
Shree Ganesh Biotech India Ltd191.31 %
Genomic Valley Biotech Ltd98861.02 %
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Adinath Bio-Labs Ltd?

Adinath Bio-Labs Ltd (590088) has a market capitalisation of Rs 6.62 Cr. at the close.

What were Adinath Bio-Labs Ltd's latest quarterly results?

In the Dec 2016 quarter, Adinath Bio-Labs Ltd sales was Rs 0 Cr (-38.9% vs Dec 2015) and net profit was Rs 0 Cr.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03